Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript

Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics' Full Year 2023 Financial Results Conference Call and Webcast.

Related Keywords

United States ,Germany ,United Kingdom ,San Diego ,California ,Japan ,Austria ,Jeff Gatseli ,Salveen Richter ,Asia Pacific ,Simon Harford ,Bradley Campbell ,Andrew Faughnan ,Morgan Stanley ,Anupam Rama ,Ellen Rosenberg ,Malcolm Kuno ,Eliana Merle ,Mitchell Goldman ,Ellie Merle ,Jeff Castelli ,Joseph Schwartz ,Sebastien Martel ,Kristen Kluska ,Goldman Sachs ,Cantor Fitzgerald ,Clinical Trial Program ,Exchange Commission ,Nasdaq ,Development Officer ,Amicus Therapeutics Inc ,Amicus Therapeutics ,Call Transcript February ,Amicus Therapeutic Full Year ,Results Conference Call ,Vice President ,Amicus Therapeutic ,Chief Executive Officer ,Chief Business Officer ,Chief Financial Officer ,Chief Development ,Chief Medical Officer ,Chief Legal ,Private Securities Litigation Reform Act ,Chief Executive ,Thanks Andrew ,Rare Disease Day ,Disease Day ,Middle East ,Pompe Disease ,Chief Development Officer ,Amicus Pompe ,Annual World Symposium ,Treatment Award ,Pompeii Phase ,Thanks Simon ,Buy According ,Future Stocks For The Long ,Ritu Baral ,Clinical Trial ,Jeff Hung ,Unidentified Analyst ,